Buradasınız

Anasayfa » Content

SALYA AKMASI (DROOLING) VE TEDAVİSİ

DROOLING AND MANAGEMENT OF DROOLING

Journal Name:

  • Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2011

Key Words:

Keywords (Original Language):

Author NameFaculty of Author
Abstract (2. Language): 
Drooling is the involuntary spillage of saliva from the mouth and it is a major morbidity associated with cerebral palsy and other neurodegenerative disorders. The consequences of drooling are not restricted to medical issues but can cause severe psycho-social consequences for the patients and their families. A team approach is the key to successful rehabilitation. Oromotor therapy is the most useful nonsurgical option. Drugs are unsuitable for long-term use due to adverse effects. Botulinum toxin A injection is promising, but no data exists on optimal dosage, duration of action and frequency of repeat injections. Bilateral submandibuler duct relocation with bilateral sublingual gland excision has been shown to be effective and safe in long-term follow-up of the largest series of patients. Other therapies which are using for drooling; anticholinergic drugs, biofeedback, behavioral and speech therapy. In this paper, drooling and developments in the management of drooling were reviewed primary based on the current literature.
Bookmark/Search this post with
Abstract (Original Language): 
Salya akması (drooling) tükürüğün ağızdan istemsiz olarak dökülmesidir ve serebral palsi ve diğer nörodejeneratif hastalıklara eşlik eden önemli bir rahatsızlıktır. Salya akması sağlık sorunlarının yanı sıra hastalar ve aileleri için ciddi psiko-sosyal problemlerle sonuçlanabilmektedir. Salya akma tedavisinde multidisipliner bir yaklaşım gereklidir. Oromotor tedavi hasta için faydalı cerrahi olmayan bir seçenektir. Cerrahi müdahale ile de başarılı sonuçların alındığı rapor edilmiştir. İlaçların ciddi yan etkileri olduğundan uzun süreli kullanımları uygun değildir. Botulinum toksin A enjeksiyonu umut verici bir tedavi olmakla birlikte optimal doz, uygulama sıklığı ve uygulama yöntemi konusunda daha fazla çalışma yapılması gerekmektedir. Bilateral sublingual kanal eksizyonu ile bilateral submandibuler kanalın yer değiştirilmesinin etkili ve güvenli tedaviler olduğu kanıtlanmıştır, fakat hastaların uzun vadeli takibini gerektirmektedir. Salya akmasının kontrol altına alınması için uygulanan diğer tedaviler antikolinerjik ilaçlar, biofeedback, davranış ve konuşma terapisidir. Bu makalede salya akması ve tedavisinde uygulanan yöntemler ile ilgili gelişmeler güncel literatür ışığında derlenmiştir.
FULL TEXT (PDF): 
PDF icon arastirmax-salya-akmasi-drooling-tedavisi.pdf
  • 2
134-140
  • Turkish

REFERENCES

References: 

1. Naghavi SE, Jalali MM. Management of drooling for patients in the north of Iran: analysis of the surgical management. JRMS 2010; 15: 1-5.
2. Lal D, Hotaling AJ. Drooling. Curr Opin Otolaryngol Head Neck Surg 2006; 14: 381-386.
3. Freeman JJ, Altieri RH, Baptiste HJ, Kuo T, Crittenden S, Fogarty K, Moultrie M, Coney E, Kanegis K. Evaluation and management of sialorrhea of pregnancy with concomitant hyperemesis. J Natl Med Assoc. 1994 Sep; 86: 704-708.
4. Cate RT. Oral Histology: development, structure, and function. 5th ed. 1998. Page 3.
5. Walsh LJ. Clinical aspects of salivary biology for the dental clinician. Int Dent S Afric 2007; 9: 22¬41.
6. Rudney J D, Smith Q T. Relationships between levels of lysozyme, lactoferrin, salivary peroxidase, and secretory immunoglobulin A in stimulated parotid saliva. Infect Immun 1985;
49: 469-475.
7. Ertekin C, Kıylıoğlu N, Tarlacı S, Turman B, Seçil Y, Aydoğdu İ. Voluntary and Reflex Influences on the Initiation of Swallowing Reflex in Man. Dysphagia 2001; 16: 40-47.
8. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005; 20: 204-207.
9. Boyce HW, Bakheet MR. Sialorrhea: a review of a vexing, often unrecognized
sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 2005;39: 89-97.
10. Tahmassebi JF, Curzon ME. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol 2003; 45:
613-617.
11. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol 2000; 42: 674-680.
12. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002; 112: 73¬81.
13. Hotaling AJ, Madgy DN, Kuhns LR, Filipek L, Belenky WM. Postoperative technetium scanning in patients with submandibuler duct diversion. Arch Otolaryngol Head Neck Surg 1992; 118:
1331-1333.
14. Jongerius PH, van LimbeekJ, Rotteveel JJ. Assessment of salivary flow rate: biologic variation and measure error. Laryngoscope 2004;
114: 1801-1804.
15. Jongerius PH, van den Hoogen FJA, van LimbeekJ, Gabreels FJ, van Hulst K, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics
2004; 114: 620-627.
16. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P.Saliva control issues in the neurologically challenged: a 30 year experience in team management. Int J Pediatr Otorhinolaryngol 2006; 70: 519-527.
17. Meningaud JP, Pitak-Arnnop P, Chikani L, Bertrand JC. Drooling of saliva: a review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;
101: 48-57.
18. Crysdale WS. The management of drooling. In: Bluestone CD, Stool SE, Alper CM, et al, editors. Pediatric otolaryngology, 4th ed. Philadelphia: Saunders; 2002. pp. 1138-1148.
19. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician 2004; 69: 2628-2634.
139
Atatürk Üniv. Diş Hek. Fak. Derg.
J Dent Fac Atatürk Uni
Cilt:21, Sayı: 2, Yıl: 2011, Sayfa: 134-140
AKGÜN, BAŞAK
20. Wong V, Sun JG, Wong W. Traditional Chinese medicine (tongue acupunc-ture) in children with drooling problems. Pediatr Neurol 2001; 25: 47¬54.
21. Jongerius PH,vanTiel P,van LimbeekJ, Gabreels FJ, Rotteveel JJ. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 2003; 88: 911-914.
22. Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the 'sausage poison'. Neurology 1999; 53:
1850-1853.
23. Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003; 61:
1279-1281.
24. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreels FJ, van Hulst K, van den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004; 63:
1371-1375.
25. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys 1998; 41: 1113-1119.
26. Andersen PM, Gronberg H, Franzen L, Funegard U. External radiation of the parotid gland significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J Neurol Sci 2001; 191: 111-114.
27. Stalpers LJA, Moser E. Results of radiotherapy for drooling in amyotrophic lateral sclerosis. Neurology 2002; 58: 1308-1310.
28. Laage-Hellman JE. Retroposition augl submandibularis utforsgong som behandling vid drazling. Nord Med 1969; 82:1522.
29. Klem C, Mair EA. Four-duct ligation: a simple and effective treatment for chronic aspiration from sialorrhea. Arch Otolaryngol Head Neck Surg
1999; 125: 796-800.
30. Wilkie TF. The problem of drooling in cerebral palsy: a surgical approach. Can J Surg 1967; 10:
60-67.
31. Stern Y, Feinmesser R, CollinsM, Shott SR, Cotton RT. Bilateral submandibulergland excision with parotid duct ligation for treatment of sialorrhea in children: long-term results. Arch Otolaryngol Head Neck Surg 2002; 128: 801¬803.

Thank you for copying data from http://www.arastirmax.com